Real estate
Takeda Pharmaceutical opened a new 24,000-square-foot R&D cell therapy manufacturing facility in Boston, Massachusetts. It is at the site of the company’s R&D headquarters.
GlaxoSmithKline has opened a new $13 million research hub in London focused on artificial intelligence.
A new 10,000 square foot facility in Marlborough, MA will allow StageBio to offer their expanded histopathology expertise and grow the company’s reach across the greater Boston region.
The drug company plans to combine its Cambridge operations at the laboratory and office building at the site by the end of the first half of 2023.
The new research hub will be called the London Discovery Research Centre and is expected to open by 2025.
JLL published its JLL 2020 U.S. Life Sciences Outlook, which ranks and tracks the progress of life sciences markets, particularly in how they relate to real estate development.
Amidst the pandemic, the biopharma industry continues to surge ahead. Jobs look plentiful. Check out these companies that have made recent job announcement expansions.
“Given the current public health crisis, we anticipate pharmaceutical and life sciences manufacturers to consider ‘reshoring’ and expanding operations in the U.S.,” said Joel Bergstein, president of LEG.
Sanofi announced plans to increase its vaccines research and production capabilities. As part of the plan it will invest $679.4 million (€610 million) to create a new production site and a research center, both in France.
Biotech companies expand their footprint and capabilities in a COVID-19 world.
PRESS RELEASES